UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased incidence of cancer in adult Gaucher disease in Western Europe

Blood cells, molecules, & diseases, 2006, Vol.36 (1), p.53-58

2006

Volltextzugriff (PDF)

The role of the iminosugar N‐butyldeoxynojirimycin (miglustat) in the management of type I (non‐neuronopathic) Gaucher disease: A position statement

Journal of inherited metabolic disease, 2003-09, Vol.26 (6), p.513-526

2003

Volltextzugriff (PDF)

Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature

Annals of hematology, 2008-06, Vol.87 (6), p.439-449

2008

Volltextzugriff (PDF)

Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature

Amino Acids, 2015-09, Vol.47 (9), p.1751-1762

2015

Volltextzugriff (PDF)

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

Blood cells, molecules, & diseases, 2018-02, Vol.68, p.203-208

2018

Volltextzugriff (PDF)

Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy

Metabolic brain disease, 2002-12, Vol.17 (4), p.453-462

2002

Volltextzugriff (PDF)

ESPEN Guidelines on Enteral Nutrition: Liver disease

Clinical nutrition (Edinburgh, Scotland), 2006-04, Vol.25 (2), p.285-294

2006

Volltextzugriff (PDF)

A multimodal approach in coil embolization of a bile leak following cholecystectomy

Cardiovascular and interventional radiology, 2007-06, Vol.30 (3), p.529-530

2007

Volltextzugriff (PDF)

Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring

Journal of inherited metabolic disease, 2008-06, Vol.31 (3), p.319-336

2008

Volltextzugriff (PDF)

Hepatic encephalopathy as a complication of liver disease

World journal of gastroenterology : WJG, 2001-04, Vol.7 (2), p.152

2001

Volltextzugriff (PDF)

1093 ACTIVATION OF INTEGRINS BY UREA IN PERFUSED RAT LIVER

Journal of hepatology, 2011-03, Vol.54, p.S433-S433

2011

Volltextzugriff (PDF)

987 UREA INDUCES A NON-OSMOTIC ACTIVATION OF THE INTEGRIN SYSTEM AND SUBSEQUENT SIGNALING CASCADES OTHERWISE INDUCED BY CELL SWELLING IN THE PERFUSED RAT LIVER

Journal of hepatology, 2010, Vol.52, p.S381-S381

2010

Volltextzugriff (PDF)

Decrease of plasma taurine in Gaucher disease and its sustained correction during enzyme replacement therapy

Amino acids, 2000-01, Vol.19 (3-4), p.585-592

2000

Volltextzugriff (PDF)

MRI bone marrow findings in 63 patients with type I Gaucher disease

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2010-11, Vol.182 (11), p.979-985

2010

Volltextzugriff (PDF)

Endoscopic therapy for leaks in the gastrointestinal tract, the bile ducts and the pancreas

Zeitschrift fur Gastroenterologie, 2011-06, Vol.49 (6), p.740

2011

Volltextzugriff (PDF)

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision

Journal of inherited metabolic disease, 2017, Vol.40 (1), p.75-101

2017

Volltextzugriff (PDF)

P.33 Novel dietary management strategies for classical homocystinuria (HCU) in HARMONY/ENSEMBLE phase 3 studies of pegtibatinase, an investigational enzyme replacement therapy

Molecular genetics and metabolism, 2024-04, Vol.141, p.108399, Article 108399

2024

Volltextzugriff (PDF)

Different dose-dependent correction of MIP-1β and chitotriosidase during initial enzyme replacement therapy

Journal of inherited metabolic disease, 2009-04, Vol.32 (2), p.274-279

2009

Volltextzugriff (PDF)

Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results

Skeletal radiology, 2001-09, Vol.30 (9), p.496-503

2001

Volltextzugriff (PDF)

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

The Lancet (British edition), 2018-09, Vol.392 (10151), p.940-949

2018

Volltextzugriff (PDF)

[289] HYDROPHOBIC BILE SALTS ACTIVATE NADPH OXIDASE THROUGH ENDOSOMAL ACIDIFICATION

Journal of hepatology, 2007, Vol.46, p.S115-S115

2007

Volltextzugriff (PDF)

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

European journal of heart failure, 2019-08, Vol.21 (8), p.998-1007

2019

Volltextzugriff (PDF)

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Circulation (New York, N.Y.), 2022-10, Vol.146 (16), p.1196-1206

2022

Volltextzugriff (PDF)

Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative

Internal medicine journal, 2019-05, Vol.49 (5), p.578-591

2019

Volltextzugriff (PDF)

1 – 25 von 440

Suche als RSS-Feed

Aktive Filter

ThemaRats

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(362)
Mit Volltextzugriff
(319)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(316)
Deutsch
(132)
Japanisch
(1)
Spanisch
(1)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(218)
Science & Technology
(199)
Life Sciences & Biomedicine
(195)
Male
(125)
Female
(120)
Middle Aged
(111)
Aged
(84)
Cardiovascular System & Cardiology
(82)
Biological And Medical Sciences
(77)
Cardiac & Cardiovascular Systems
(77)
Medical Sciences
(74)
Adult
(69)
Medicine
(37)
Coronary Angiography
(36)
Medicine & Public Health
(34)
Follow-Up Studies
(32)
Stents
(31)
Radiology, Nuclear Medicine & Medical Imaging
(30)
Treatment Outcome
(30)
Coronary Disease - Diagnostic Imaging
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased incidence of cancer in adult Gaucher disease in Western Europe

The role of the iminosugar N‐butyldeoxynojirimycin (miglustat) in the management of type I (non‐neuronopathic) Gaucher disease: A position statement

Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature

Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy

ESPEN Guidelines on Enteral Nutrition: Liver disease

A multimodal approach in coil embolization of a bile leak following cholecystectomy

Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring

Hepatic encephalopathy as a complication of liver disease

1093 ACTIVATION OF INTEGRINS BY UREA IN PERFUSED RAT LIVER

987 UREA INDUCES A NON-OSMOTIC ACTIVATION OF THE INTEGRIN SYSTEM AND SUBSEQUENT SIGNALING CASCADES OTHERWISE INDUCED BY CELL SWELLING IN THE PERFUSED RAT LIVER

Decrease of plasma taurine in Gaucher disease and its sustained correction during enzyme replacement therapy

MRI bone marrow findings in 63 patients with type I Gaucher disease

Endoscopic therapy for leaks in the gastrointestinal tract, the bile ducts and the pancreas

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision

P.33 Novel dietary management strategies for classical homocystinuria (HCU) in HARMONY/ENSEMBLE phase 3 studies of pegtibatinase, an investigational enzyme replacement therapy

Different dose-dependent correction of MIP-1β and chitotriosidase during initial enzyme replacement therapy

Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation

[289] HYDROPHOBIC BILE SALTS ACTIVATE NADPH OXIDASE THROUGH ENDOSOMAL ACIDIFICATION

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative

Aktive Filter

Suchergebnisse filtern